Biotech & Healthcare CompaniesGRAIL Stock Falls 20% After NHS Cancer Detection Trial Misses Primary EndpointSalvado•May 27, 2026
Corporate M&AQuest's Haystack Oncology Acquisition Faces Deal Repricing Risk on Technology Validation GapsViaNews Editorial Team (Finance)•Feb 22, 2026
